Mersana Therapeutics, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Mersana Therapeutics, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Corporate Presentation

Aug 13, 2025

Slides

Q2 2025

Aug 13, 2025

Earnings release8-K

Quarterly report10-Q

Transcript

Q1 2025

May 15, 2025

Earnings release8-K

Quarterly report10-Q

Transcript

Guggenheim SMID Cap Biotech Conference

Feb 6, 2025

Transcript

Study Update

Jan 10, 2025

Press release

Slides

2024

Q4 2024

Mar 3, 2025

Annual report10-K

Earnings release8-K

Transcript

Q3 2024

Nov 13, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 13, 2024

Earnings release8-K

Quarterly report10-Q

Q1 2024

May 9, 2024

Earnings release8-K

Quarterly report10-Q

Corporate Presentation

Feb 28, 2024

Slides

Corporate Presentation

Jan 5, 2024

Slides

2023

Q4 2023

Feb 28, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 7, 2023

Earnings release8-K

Quarterly report10-Q

Q2 2023

Aug 8, 2023

Earnings release8-K

Quarterly report10-Q

Q1 2023

May 9, 2023

Earnings release8-K

Quarterly report10-Q

2022

Q4 2022

Feb 28, 2023

Annual report10-K

Earnings release8-K

Q3 2022

Nov 7, 2022

Earnings release8-K

Quarterly report10-Q

Q2 2022

Aug 8, 2022

Earnings release8-K

Quarterly report10-Q

Q1 2022

May 9, 2022

Earnings release8-K

Quarterly report10-Q

2021

Q4 2021

Feb 28, 2022

Annual report10-K

2020

Q4 2020

Feb 26, 2021

Annual report10-K

2019

Q4 2019

Feb 28, 2020

Annual report10-K

2018

Q4 2018

Mar 8, 2019

Annual report10-K

2017

Q4 2017

Mar 28, 2018

Annual report10-K